158 related articles for article (PubMed ID: 22380786)
1. Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases.
Angata T; Fujinawa R; Kurimoto A; Nakajima K; Kato M; Takamatsu S; Korekane H; Gao CX; Ohtsubo K; Kitazume S; Taniguchi N
Ann N Y Acad Sci; 2012 Apr; 1253():159-69. PubMed ID: 22380786
[TBL] [Abstract][Full Text] [Related]
2. Discovering new clinical markers in the field of glycomics.
Telford JE; Doherty MA; Tharmalingam T; Rudd PM
Biochem Soc Trans; 2011 Jan; 39(1):327-30. PubMed ID: 21265797
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
4. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
5. Computational biology for cardiovascular biomarker discovery.
Azuaje F; Devaux Y; Wagner D
Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
[TBL] [Abstract][Full Text] [Related]
6. Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.
Tharmalingam T; Mariño K; Rudd PM
Carbohydr Res; 2010 Jul; 345(10):1280-2. PubMed ID: 20447618
[TBL] [Abstract][Full Text] [Related]
7. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 2.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Apr; 15(4):341-352. PubMed ID: 29521143
[TBL] [Abstract][Full Text] [Related]
8. Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome.
Atiomo WU; Khalid S; Ziauddin A; Tooth D; Layfield R
Expert Rev Proteomics; 2009 Oct; 6(5):469-99. PubMed ID: 19811070
[TBL] [Abstract][Full Text] [Related]
9. High-throughput glycoanalytical technology for systems glycobiology.
Liu L; Telford JE; Knezevic A; Rudd PM
Biochem Soc Trans; 2010 Oct; 38(5):1374-7. PubMed ID: 20863316
[TBL] [Abstract][Full Text] [Related]
10. Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies.
Zoldoš V; Horvat T; Lauc G
Curr Opin Chem Biol; 2013 Feb; 17(1):34-40. PubMed ID: 23287290
[TBL] [Abstract][Full Text] [Related]
11. Glycans in cancer and inflammation--potential for therapeutics and diagnostics.
Dube DH; Bertozzi CR
Nat Rev Drug Discov; 2005 Jun; 4(6):477-88. PubMed ID: 15931257
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
[TBL] [Abstract][Full Text] [Related]
13. Rise of Systems Glycobiology and Personalized Glycomedicine: Why and How to Integrate Glycomics with Multiomics Science?
Kunej T
OMICS; 2019 Dec; 23(12):615-622. PubMed ID: 31651212
[TBL] [Abstract][Full Text] [Related]
14. Glycomics: an integrated systems approach to structure-function relationships of glycans.
Raman R; Raguram S; Venkataraman G; Paulson JC; Sasisekharan R
Nat Methods; 2005 Nov; 2(11):817-24. PubMed ID: 16278650
[TBL] [Abstract][Full Text] [Related]
15. The use of high-throughput technologies to investigate vascular inflammation and atherosclerosis.
Döring Y; Noels H; Weber C
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):182-95. PubMed ID: 22258901
[TBL] [Abstract][Full Text] [Related]
16. The application of NMR spectroscopy to functional glycomics.
Brisson JR; Vinogradov E; McNally DJ; Khieu NH; Schoenhofen IC; Logan SM; Jarrell H
Methods Mol Biol; 2010; 600():155-73. PubMed ID: 19882127
[TBL] [Abstract][Full Text] [Related]
17. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
Villoslada P; Baranzini S
J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
[TBL] [Abstract][Full Text] [Related]
18. Databases and tools in glycobiology.
Artemenko NV; McDonald AG; Davey GP; Rudd PM
Methods Mol Biol; 2012; 899():325-50. PubMed ID: 22735963
[TBL] [Abstract][Full Text] [Related]
19. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
20. An "Omics" based survey of human colon cancer.
Nambiar PR; Gupta RR; Misra V
Mutat Res; 2010 Nov; 693(1-2):3-18. PubMed ID: 20691711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
